British Journal of Anaesthesia, 2002, Vol. 89, No. 4 567-570
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia
Clinical Investigations |
Remifentanil compared with sufentanil during extra-corporeal shock wave lithotripsy with spontaneous ventilation: a double-blind, randomized study
1 Department of Anaesthesiology and Critical Care and 2 Department of Emergency Medicine and Surgery, Groupe hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Pierre et Marie Curie, Paris, France*Corresponding author: Départment dAnesthésie-Réanimation, Groupe hospitalier Pitié-Salpêtrière, 47 Boulevard de lHôpital, F-75651 Paris cedex 13, France
Background. The pharmacokinetic properties of remifentanil may allow a rapid analgesic action during painful procedures and short lasting postoperative respiratory depression.
Methods. We carried out a randomized, blind, study in 60 patients to compare remifentanil (continuous i.v. infusion starting at 0.025 µg kg1 min1) and sufentanil (i.v. doses of 0.15 µg kg1) during extra-corporeal shock wave lithotripsy (ESWL). Pain was assessed using a numerical pain scale (0100), and pain relief was defined as a score
30. Respiratory depression was defined as a ventilatory frequency less than10 breaths min1 on two occasions or a peripheral oxygen saturation
92%, or administration of naloxone.
Results. The quality of analgesia was similar in both groups, during and after ESWL. During ESWL, there was no significant difference in respiratory depression in the remifentanil and sufentanil groups (53 vs 73%, NS). The percentage of satisfied patients (73 vs 83%, NS) and satisfied surgeons (97 vs 100%, NS) did not significantly differ between groups. After the procedure patients given remifentanil had less respiratory depression (20 vs 53%, P<0.05) and less nausea and vomiting (3 vs 20%, P<0.05).
Conclusion. A continuous i.v. infusion of remifentanil provided comparable analgesia and caused less respiratory depression and nausea and vomiting than i.v. boluses of sufentanil in patients undergoing extra-corporeal shock wave lithotripsy.
Br J Anaesth 2002; 89: 56770
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. A. Alhashemi and A. M. Kaki Anesthesiologist-controlled versus patient-controlled propofol sedation for shockwave lithotripsy: [La sedation au propofol controlee par l'anesthesiologiste ou le patient pour la lithotripsie par ondes de choc]. Can J Anesth, May 1, 2006; 53(5): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Medina, E. M. Galvin, M. Dirckx, P. Banwarie, J. F. H. Ubben, F. J. Zijlstra, J. Klein, and S. J. C. Verbrugge Remifentanil as a Single Drug for Extracorporeal Shock Wave Lithotripsy: A Comparison of Infusion Doses in Terms of Analgesic Potency and Side Effects Anesth. Analg., August 1, 2005; 101(2): 365 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Alhashemi and A. M. Kaki Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy: [La dexmedetomidine combinee a la morphine en AAC fournit une analgesie superieure pour la lithotripsie par ondes de choc] Can J Anesth, April 1, 2004; 51(4): 342 - 347. [Abstract] [Full Text] [PDF] |
||||

